Blog
RSS FeedPosted by Michael Wonder on 05 Jun 2019
NHS publishes update on the use of biosimilars
5 June 2019 - The United Kingdom’s National Health Service (NHS) has published a new document for clinical and nonclinical ...
Posted by Michael Wonder on 04 Jun 2019
Biosimilar uptake drivers - etanercept
3 June 2019 - Information about Government initiatives to encourage the use of biosimilars is now available on the PBS website. ...
Posted by Michael Wonder on 28 May 2019
Canadian Biosimilars Forum applauds B.C. Government's landmark decision to enhance adoption of biosimilars and calls on remaining provinces to follow
27 May 2019 - The Canadian Biosimilars Forum today commends the Government of British Columbia for taking a decisive step ...
Posted by Michael Wonder on 28 May 2019
BC PharmaCare’s Biosimilars Initiative an important step towards improving patient access to safe and effective medicines
27 May 2019 - Biosimilars Initiative implementation could contribute to significant cost savings for the BC health care system. ...
Posted by Michael Wonder on 27 May 2019
B.C. becomes first province to force change to biosimilar drugs
27 May 2019 - The change will save the government nearly $100 million over the next three years. ...
Posted by Michael Wonder on 23 May 2019
Biosimilars no longer reviewed through the CADTH CDR and pCODR processes
23 May 2019 - When CADTH launched a new, streamlined biosimilar review process in February 2018, we committed to evaluating ...
Posted by Michael Wonder on 13 May 2019
HTA frameworks for RA therapies need improvement, researchers say
13 May 2019 - Cost-effectiveness models for the treatment of rheumatoid arthritis first emerged in the early 2000s when highly effective ...
Posted by Michael Wonder on 13 May 2019
Australia's GBMA launches hub for biosimilar education
13 May 2019 - In 2018, the Generic Biosimilar Medicines Association was awarded the Biosimilar Education Grant by the Australian government ...
Posted by Michael Wonder on 25 Mar 2019
One Canadian payer's experience with biosimilars
25 March 2019 - Much of the discussion about biosimilar uptake revolves around challenges in the United States, but other ...
Posted by Michael Wonder on 21 Feb 2019
Canada finds "insufficient evidence" that Janssen blocked biosimilar competition
21 February 2019 - Despite the fact that the investigation confirmed many of the allegations against Janssen, the bureau concluded that, ...
Posted by Michael Wonder on 14 Feb 2019
Quebec appeals court orders province to restore full coverage of rheumatoid-arthritis drug Remicade
13 February 2019 - Quebec’s highest court has ordered the provincial government to restore full public coverage of Remicade, an ...
Posted by Michael Wonder on 05 Feb 2019
Biosimilar uptake drivers
5 February 2019 - Information about Government initiatives to encourage the use of biosimilars is now available on the PBS website. ...
Posted by Michael Wonder on 21 Jan 2019
Canadian payer reports a successful switch to biosimilars
21 January 2019 - In 2018, Green Shield Canada launched its pilot Biosimilar Transition Program, through 3 plan sponsors, under which ...
Posted by Michael Wonder on 27 Nov 2018
NHS saves record £300 million by switching to cheaper arthritis drug
26 November 2018 - The NHS is set to save a record £300 million after negotiating deals with five manufacturers ...
Posted by Michael Wonder on 15 Nov 2018
German health minister calls for faster adoption of biosimilar drugs
14 November 2018 - Germany’s health minister Jens Spahn has called for faster adoption of cheaper copies of biotech drugs ...